Transjugular intrahepatic portosystemic shunts vs Conventional treatment
Participants who did not receive a liver transplant · adults with hepatorenal syndrome
It is very uncertain whether transjugular intrahepatic portosystemic shunts changes participants who did not receive a liver transplant compared with conventional treatment (very low certainty).
1 finding from 1 review
- Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome 2024 · Cochrane Headline outcomes onlyRR 1.03 [0.93, 1.14]2 studies · 130 participantsVery low